ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY

被引:0
|
作者
CUDA, G
FANANAPAZIR, L
EPSTEIN, ND
SELLERS, JR
机构
[1] NHLBI,CARDIOL BRANCH,BETHESDA,MD 20892
[2] NHLBI,CLIN HEMATOL BRANCH,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:A362 / A362
页数:1
相关论文
共 50 条
  • [21] Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy
    Van Driest, SL
    Jaeger, MA
    Ommen, SR
    Will, ML
    Gersh, BJ
    Tajik, AJ
    Ackerman, MJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (03) : 602 - 610
  • [22] The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy
    Cuda, G
    Fananapazir, L
    Epstein, ND
    Sellers, JR
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1997, 18 (03) : 275 - 283
  • [23] beta-myosin heavy chain-linked hypertrophic cardiomyopathy: A study of a population from south Italy
    Cuda, G
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1996, 17 (01) : 99 - 100
  • [24] IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY
    FANANAPAZIR, L
    WINKLER, JB
    SATORIUS, C
    EPSTEIN, ND
    CIRCULATION, 1994, 90 (04) : 442 - 442
  • [25] A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy
    Jaaskelainen, Pertti
    Helio, Tiina
    Aalto-Setala, Katriina
    Kaartinen, Maija
    Ilveskoski, Erkki
    Hamalainen, Liisa
    Melin, John
    Karkkainen, Satu
    Peuhkurinen, Keijo
    Nieminen, Markku S.
    Laakso, Markku
    Kuusisto, Johanna
    ANNALS OF MEDICINE, 2014, 46 (06) : 424 - 429
  • [26] Hypertrophic cardiomyopathy due to beta-myosin heavy chain mutation with extreme phenotypic variability within a family
    Keller, D. I.
    Schwitter, J.
    Valsangiacomo, E. R.
    Landolt, P.
    Jost, C. H. Attenhofer
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : E87 - E93
  • [27] Genetic screening in hypertrophic cardiomyopathy: Most beta-myosin mutations that are identified are novel with undefined clinical outcomes
    Mohiddin, SA
    Winkler, J
    MClam, E
    Begley, DA
    Fananapazir, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 174A - 174A
  • [28] ABNORMAL CONTRACTILE PROPERTIES OF MUSCLE-FIBERS EXPRESSING BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    LANKFORD, EB
    EPSTEIN, ND
    FANANAPAZIR, L
    SWEENEY, HL
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03): : 1409 - 1414
  • [29] Systolic dysfunction in hypertrophic cardiomyopathy caused by Arg723Gly mutation in the beta-myosin gene
    Navarro-Lopez, F.
    Francino, A.
    Pare, J. C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 539 - 539
  • [30] HYPERTROPHIC CARDIOMYOPATHY - FAILURE TO DEMONSTRATE MUTATIONS IN EXON 13 OF THE CARDIAC BETA-MYOSIN HEAVY-CHAIN GENE
    FRIEDMAN, E
    GORDELADZE, JO
    GEJMAN, PV
    MURTAGH, JJ
    GERTCH, DS
    TU, T
    BASIC RESEARCH IN CARDIOLOGY, 1992, 87 (02) : 106 - 112